SAFE Agreement Lawyers for New York
Need help with a SAFE agreement in New York?
ContractsCounsel connects businesses and individuals with experienced SAFE agreement lawyers across New York to help with drafting, reviewing, and negotiating your legal agreements.
Quick Facts — SAFE Agreement Lawyers (New York)
- Avg cost to draft a SAFE Note: $640.00
- Avg cost to review a SAFE Note: $280.00
- Lawyers available: 48 New York startup lawyers
- Clients helped: 22 recent SAFE agreement projects in New York
- Avg lawyer rating: 4.83 (6 reviews)
Meet some of our New York SAFE Agreement Lawyers
Ted A.
Equity Investments, Agreements & Transactions | Securities & Lending | Corporate Governance | Complex Commercial Contracts | Outside General Counsel & Compliance
"Ted was extremely responsive, knowledgeable, easy to work with and was able help me the same day. I would confidently recommend him in the future."
Max K.
Transactional attorney with experience in drafting, reviewing and negotiating contracts, licenses, leases, general business practices and dispute resolution. Licensed in Nevada, California and New York. I never charge for phone calls - happy to chat. www.linkedin.com/in/maxkelner
"This was my 1st time having to consult with a legal expert about anything and Max made the process easy and stress-free."
Scott S.
I have over 25 years' experience representing individual and company clients, large and small, in transactions such as mergers and acquisitions, private offerings of securities, commercial loans and commercial endeavors (supply contracts, manufacturing agreements, joint ventures, intellectual property licenses, etc.). My particular specialty is in complex and novel drafting.
"Scott is *very* talented - he quickly understood what I was looking for and expertly prepared the needed documents. Would recommend and definitely will be working with him again!"
Michael S.
I began my career at "big law" firms, worked in-house for 14 years, and now have my own practice, providing big law quality at small firm rates. My practice focuses on strategic and commercial transactions, including M&A, preferred stock and common stock offerings, asset purchases and sales, joint ventures and strategic partnerships, stock option plans, master services agreements and SOWs, software development and license agreements, SaaS agreements, NDAs, employment and consulting agreements. I also manage corporate governance, advise boards and executives, and act as outside general counsel. I represent clients across the country and around the world.
"Quick, helpful response and a very fair price. I’m grateful for the help!"
Joshua S.
Joshua is an experienced attorney with deep expertise in finance, corporate, and business law. He offers practical legal solutions and personal service. As Managing Partner of Soloway Group PC, he advises startups, growing companies and investment funds on key issues, from formation to fundraising, stock issuances, trademarks and general business. He started out structuring funds and transactions at PwC before launching his own firm in 2009. He has been a partner in several New York law firms and has founded several companies including a banking firm, a real estate business, and a Cleantech company. Joshua has also served as Chief Legal Officer and Chief Strategy Officer of several companies in the tech, real estate, consulting, and sustainability industries. Prior to law school he was an early employee at a SoftBank-backed startup until it’s acquisition. Over the years, Joshua has helped many clients to launch, finance and grow successfully.
"Very competent attorney who gets to the point quickly and cheerfully."
Odini G.
I am an accomplished attorney with more than 19 years of experience and extensive expertise in business negotiations, commercial contracts, and technology transactions. With a proven track record of providing strategic legal advice and delivering exceptional results, I have successfully assisted numerous clients in drafting, reviewing, and negotiating various business arrangements. My experience encompasses a wide range of areas, including intellectual property, data privacy and security, SaaS agreements, and software licenses. I co-founded a reputable general corporate law firm with three offices in Aspen, Atlanta, and New York. As a partner and attorney, I represented diverse clients, including start-ups, public corporations, investors, financial institutions, educational institutions, and non-profit entities. With a focus on delivering comprehensive legal solutions, I provided general counsel, expert dispute resolution, efficient litigation management, and skillful contract drafting and negotiations for businesses across industries.
"Supremely responsive and works surprisingly quickly. Strongly recommend!"
September 29, 2024
Leah R F.
Newly admitted associate who is eager to make legal advice accessible and affordable!
August 19, 2024
Michael L.
Solo practitioner, licensed in New York State 27+ years. Areas of practice: Small Business Law, Commercial Contracts, Commercial Litigation, Employment Law & Litigation, Estate Planning, Business Succession Planning.
September 27, 2024
Jo Ann G.
Provides outside general counsel advice to corporate or individual clients with a vast range of legal and business matters. Has extensive general counsel experience in a wide range of legal areas. Has a background as an in house general counsel in the manufacturing, retail and consumer goods industries.
October 8, 2024
Benjamin D.
Benjamin I. Dach, Ph.D., Esq. is an accomplished patent attorney with extensive experience across multiple fields, including intellectual property (IP) litigation, counseling, and prosecution, spanning copyrights, trademarks, and patents. Prior to Weiss & Arons LLP, Benjamin worked at several prestigious law firms, including Quinn Emanuel LLP, WilmerHale LLP, Loeb & Loeb LLP, and Haug Partners LLP. During his decade-plus of legal work experience, Benjamin has litigated several pharmaceutical patent cases involving drugs such as Lialda, Vyvanse, Intuniv, Oxtellar XR, Pomalyst, Revlimid, and Cabometyx. Benjamin has also drafted and prosecuted dozens of patent applications, and counseled clients on IP relating to biological drugs, messenger ribonucleic acid (mRNA) vaccines, and clustered randomly interspaced palindromic repeats (CRISPR). Benjamin earned his Ph.D. in chemistry from Columbia University, where his research focused on solid-phase polymer synthesis on silicon wafers and silica nanoparticles, with applications in drug delivery, solar energy, and semiconductors. His thesis, titled "Designer Polymer Superstructures from Solid Phase 'Click' Chemistry," highlights his expertise in the field. In addition to his scientific background, Benjamin also holds a J.D. from Fordham Law School, with a concentration in intellectual property and information law. Benjamin leverages his technical and legal backgrounds to maximize the value of his clients' IP portfolios. His strong commitment to science and law has made him a highly sought-after attorney in the areas of copyright, trademark, and patent law. Rated by Super Lawyers, Benjamin was selected to Rising Stars in Law. He is admitted to practice law in Florida, New York, New Jersey, and before the United States Patent and Trademark Office.
Find the best lawyer for your project
Browse Lawyers NowFrequently Asked Questions
See Real SAFE Note Projects
New York Review signed angel investor documents and outline options for selling or getting investment returned Review
- New York
- 12 lawyer bids
- $75 - $900
Lawyer Reviews for New York SAFE Agreement Projects
Review signed angel investor documents and outline options for selling or getting investment returned
"Morgan was fantastic. He quickly reviewed my document and answered all my questions. I highly recommend him."
Find SAFE Note Templates by Type
A Pre-Money SAFE Note is a financial instrument used by startups and investors in early-stage funding. It's an agreement that provides investors the right to purchase equity in the company at a future date, typically during a future equity financing round, sale, or IPO.
The terms "Pre-Money" refer to the valuation of the company before the current round of financing. This means the valuation would not take into account the money invested in the financing round. For example, if the company receives a valuation of $10 million to raise $2 million, the "Pre-Money" valuation is $10 million and "Post-Money" valuation is $12 million (includes the money from the financing round).
- Valuation Cap: The valuation cap is a maximum valuation at which the SAFE can convert into equity. This protects investors from over-dilution if the company's valuation increases significantly before the SAFE converts. For example, if a SAFE has a valuation cap of $5 million and the company's valuation in the next funding round is $10 million, the SAFE holder’s investment converts as if the company was valued at only $5 million, offering more shares for the same investment compared to later investors.
A SAFE Note is a financial instrument used by startups and investors in early-stage funding. It's an agreement that provides investors the right to purchase equity in the company at a future date, typically during a future equity financing round, sale, or IPO. Given this SAFE Note has no valuation cap included, it does not need to reference "Pre-Money" or "Post-Money" since the valuation at the triggering event will not impact the price the investors shares are converted. It will only be converted at the discount.
- Discount: This is a feature that gives investors a discounted price compared to what later investors pay in a future financing round. For example, if a SAFE note carries a 20% discount and the price per share in the next funding round is $1.00, the SAFE holder would be able to convert their investment into equity at $0.80 per share. This discount compensates early investors for their higher risk.
A Pre-Money SAFE Note is a financial instrument used by startups and investors in early-stage funding. It's an agreement that provides investors the right to purchase equity in the company at a future date, typically during a future equity financing round, sale, or IPO.
The terms "Pre-Money" refer to the valuation of the company before the current round of financing. This means the valuation would not take into account the money invested in the financing round. For example, if the company receives a valuation of $10 million to raise $2 million, the "Pre-Money" valuation is $10 million and "Post-Money" valuation is $12 million (includes the money from the financing round).
- Discount: This is a feature that gives investors a discounted price compared to what later investors pay in a future financing round. For example, if a SAFE note carries a 20% discount and the price per share in the next funding round is $1.00, the SAFE holder would be able to convert their investment into equity at $0.80 per share. This discount compensates early investors for their higher risk.
- Valuation Cap: The valuation cap is a maximum valuation at which the SAFE can convert into equity. This protects investors from over-dilution if the company's valuation increases significantly before the SAFE converts. For example, if a SAFE has a valuation cap of $5 million and the company's valuation in the next funding round is $10 million, the SAFE holder’s investment converts as if the company was valued at only $5 million, offering more shares for the same investment compared to later investors.
A Post-Money SAFE Note is a financial instrument used by startups and investors in early-stage funding. It's an agreement that provides investors the right to purchase equity in the company at a future date, typically during a future equity financing round, sale, or IPO.
The terms "Post-Money" refer to the valuation of the company after the current round of financing. This means the valuation would take into account the money invested in the financing round. For example, if the company receives a valuation of $10 million to raise $2 million, the "Pre-Money" valuation is $10 million and "Post-Money" valuation is $12 million (includes the money from the financing round).
- Discount: This is a feature that gives investors a discounted price compared to what later investors pay in a future financing round. For example, if a SAFE note carries a 20% discount and the price per share in the next funding round is $1.00, the SAFE holder would be able to convert their investment into equity at $0.80 per share. This discount compensates early investors for their higher risk.
- Valuation Cap: The valuation cap is a maximum valuation at which the SAFE can convert into equity. This protects investors from over-dilution if the company's valuation increases significantly before the SAFE converts. For example, if a SAFE has a valuation cap of $5 million and the company's valuation in the next funding round is $10 million, the SAFE holder’s investment converts as if the company was valued at only $5 million, offering more shares for the same investment compared to later investors.
A Post-Money SAFE Note is a financial instrument used by startups and investors in early-stage funding. It's an agreement that provides investors the right to purchase equity in the company at a future date, typically during a future equity financing round, sale, or IPO.
The terms "Post-Money" refer to the valuation of the company after the current round of financing. This means the valuation would take into account the money invested in the financing round. For example, if the company receives a valuation of $10 million to raise $2 million, the "Pre-Money" valuation is $10 million and "Post-Money" valuation is $12 million (includes the money from the financing round).
- Discount: This is a feature that gives investors a discounted price compared to what later investors pay in a future financing round. For example, if a SAFE note carries a 20% discount and the price per share in the next funding round is $1.00, the SAFE holder would be able to convert their investment into equity at $0.80 per share. This discount compensates early investors for their higher risk.
- Valuation Cap: The valuation cap is a maximum valuation at which the SAFE can convert into equity. This protects investors from over-dilution if the company's valuation increases significantly before the SAFE converts. For example, if a SAFE has a valuation cap of $5 million and the company's valuation in the next funding round is $10 million, the SAFE holder’s investment converts as if the company was valued at only $5 million, offering more shares for the same investment compared to later investors.
Quick, user friendly and one of the better ways I've come across to get ahold of lawyers willing to take new clients.
View Trustpilot ReviewNeed help with a SAFE Agreement?
Startup lawyers by top cities
- Austin Startup Lawyers
- Boston Startup Lawyers
- Chicago Startup Lawyers
- Dallas Startup Lawyers
- Denver Startup Lawyers
- Houston Startup Lawyers
- Los Angeles Startup Lawyers
- New York Startup Lawyers
- Phoenix Startup Lawyers
- San Diego Startup Lawyers
- Tampa Startup Lawyers
New York SAFE Agreement lawyers by city
- Albany SAFE Agreement Lawyers
- Buffalo SAFE Agreement Lawyers
- New York SAFE Agreement Lawyers
- Rochester SAFE Agreement Lawyers
- Syracuse SAFE Agreement Lawyers
- Yonkers SAFE Agreement Lawyers
ContractsCounsel User
SAFE Note Review
Location: New York
Turnaround: Less than a week
Service: Contract Review
Doc Type: SAFE Note
Page Count: 8
Number of Bids: 10
Bid Range: $400 - $750
ContractsCounsel User